Phase II study on the neoadjuvant use of chemotherapy and celecoxib therapy in patients with invasive breast cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antineoplastics; Celecoxib
- Indications Breast cancer
- Focus Therapeutic Use
- 24 May 2012 Biomarkers information updated
- 23 May 2012 Inclusion and exclusion criteria amended as reported by ClinicalTrials.gov.
- 23 May 2012 Additional lead trial centre and investigator (Louis WC Chow) identified as reported by ClinicalTrials.gov.